Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Tranexamic Acid in Total Shoulder Arthroplasty
NCT06902714Phase 3Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing oral tranexamic acid with Oral Placebo (2 arms). Primary endpoint: Visual Analog Scale at 2 weeks. Started Apr 2026; status: recruiting.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT06902714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06902714.